Inactive Instrument

Calendar Organovo Holdings Inc Nyse

Equities

US68620A1043

End-of-day quote Nyse Other stock markets
- ^USD	-

Apr. 15	Organovo's fatty liver disease drug meets main goal in mid-stage study	RE
Apr. 15	Organovo Holdings, Inc. Announces Positive Phase 2 Results for FXR314 in Metabolic Dysfunction-Associated Steatohepatitis Showing Both Reduction in Liver Fat Content and Strong Safety and Tolerability Compared to Placebo	CI

Chart calendar Organovo Holdings Inc

d0d8ad0953a72e03.zwmy3-Ol6TiB_7CJwObeDg8gHjidPWFuITVTO6YevUk.t3GK56fxnA3Xz9v4ldHpfkZYbXnrRVEoa1YXXdNpiACFSuWLudCjbPOo-Q~da236bfb3e59fd8a4cfe9fb2c03e3ba3

Upcoming events on Organovo Holdings Inc

No events available

Past events on Organovo Holdings Inc

2024-01-26 06:00 pm	Crohn & Colitis Congress
2023-10-31 12:00 pm	Annual General Meeting
2023-09-11 10:00 am	H.C. Wainwright Global Investment Conference
2022-10-12 12:00 pm	Annual General Meeting
2022-09-12 07:00 am	H.C. Wainwright Global Investment Conference
2021-10-05 12:00 pm	Annual General Meeting - Second Call
2021-09-14 12:00 pm	Annual General Meeting
2021-03-08	H.C. Wainwright Global Life Science Conference
2020-09-15 12:00 pm	Annual General Meeting
2020-08-18	Reverse Split: 1 of 20
2020-04-07 01:00 pm	Extraordinary Shareholders Meeting
2020-03-25	Extraordinary Shareholders Meeting - M&A Vote
2019-12-16 08:30 am	Tarveda Therapeutics Inc. and Organovo Holdings, Inc. Merger Call
2019-09-05 12:00 pm	Annual General Meeting
2019-08-07	Q1 2020 Earnings Release
2019-06-18 01:15 pm	Raymond James Life Sciences & MedTech Conference
2019-05-22 05:00 pm	FY 2019 Earnings Call
2019-05-21	FY 2019 Earnings Release
2019-04-22	Alliance for Regenerative Medicine Cell & Gene Meeting
2019-02-07 05:00 pm	Q3 2019 Earnings Call

Annual results

Fiscal Period	March	2019	2023
Net sales Million USD	Released Forecast Spread	3,09 3,25 -4.98%	0,00
EBITDA	Released Forecast Spread	0,00 0,00 -	0,00
EBIT Million USD	Released Forecast Spread	-27,3 -28,1 2.92%	0,00
Earnings before Tax (EBT) Million USD	Released Forecast Spread	-26,6 -27,0 1.36%	0,00
Net income Million USD	Released Forecast Spread	-26,6 -27,0 1.35%	-17,3
EPS USD	Released Forecast Spread	-4,60 -4,80 4.17%	-1,98
Announcement Date		22/05/19	14/07/23

Quarterly results

Fiscal Period	March	2024 Q1	2024 Q2	2024 Q3
Net sales Million USD	Released Forecast Spread		0,00 0,08 -	0,01 0,08 -93.33%
EBIT Million USD	Released Forecast Spread		-4,12 -4,24 2.9%	-3,68 -4,08 9.83%
Net income Million USD	Released Forecast Spread	-4,03	-3,99 -3,76 -6.28%	-3,60 -3,60 -0.03%
EPS USD	Released Forecast Spread	-0,46	-0,46 -0,43 -6.98%	-0,40 -0,41 2.44%
Announcement Date		10/08/23	09/11/23	08/02/24

Upcoming sector events for Organovo Holdings Inc

Today 04:05 pm	QIAGEN N.V.: Q1 2024 Earnings Release
2024-04-29	CRISPR THERAPEUTICS AG: Q1 2024 Earnings Release (Projected)
2024-04-30	DYNE THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected)
2024-04-30	PROTAGONIST THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected)
2024-04-30	EDITAS MEDICINE, INC.: Q1 2024 Earnings Release (Projected)
2024-04-30	AZENTA, INC.: Q2 2024 Earnings Release (Projected)
2024-05-01 06:30 am	UNITED THERAPEUTICS CORPORATION: Q1 2024 Earnings Release
2024-05-01 06:30 am	BIO-TECHNE CORPORATION: Q3 2024 Earnings Release
2024-05-01 07:00 am	ALKERMES PLC: Q1 2024 Earnings Release
2024-05-01	VIR BIOTECHNOLOGY, INC.: Q1 2024 Earnings Release

More events

Past sector events for Organovo Holdings Inc

Today	BEIJING SUN-NOVO PHARMACEUTICAL RESEARCH CO., LTD.: Q1 2024 Earnings Release (Projected)
Today	SINO BIOLOGICAL,INC.: Q1 2024 Earnings Release
Today	JOINN LABORATORIES(CHINA)CO.,LTD.: Q1 2024 Earnings Release
Today	MORPHOSYS AG: Q1 2024 Earnings Release
2024-04-26	GEMPHARMATECH CO., LTD.: Q1 2024 Earnings Release
2024-04-26	GEMPHARMATECH CO., LTD.: Q4 2023 Earnings Release
2024-04-26 01:00 am	BB BIOTECH AG: Q1 2024 Earnings Release
2024-04-25	BIDE PHARMATECH CO., LTD.: Q4 2023 Earnings Release
2024-04-25	PHARMARESOURCES (SHANGHAI) CO., LTD.: Q1 2024 Earnings Release
2024-04-25	HINOVA PHARMACEUTICALS INC.: Q1 2024 Earnings Release (Projected)